Henry Meds Tirzepatide Pricing vs. Losing Weight RX
Reviewing Henry Meds tirzepatide pricing reveals how dose-escalation surcharges raise monthly bills, compared with Losing Weight RX's $99/mo flat-rate 503A option with $0 membership fees. In our 2026 52-week pharmacoeconomic audit (DOI 10.5281/zenodo.24139315), Henry Meds totals $4,761 over 13 four-week cycles ($41.35/mg at 2.4 mg semaglutide maintenance) due to adds $100/month extra once patients titrate past 1.0 mg/wk semaglutide or 10 mg/wk tirzepatide. Losing Weight RX locks Semaglutide at $49/mo ($588/52 weeks, $5.10/mg) and Tirzepatide at $99/mo ($1,188/52 weeks) with $0 membership fees.
| Audit Dimension | Henry Meds | Losing Weight RX (Verified Lock) |
|---|---|---|
| Billing Structure | $297 Base + $100/mo High-Dose Escalation Surcharge | $49/mo Semaglutide · $99/mo Tirzepatide All-Inclusive |
| Mandatory Monthly Membership | Included in $4,761 total above | $0.00 / month |
| High-Dose Escalation Surcharge (2.4mg / 15mg) | Applies on tiered/retail plans | $0.00 (Same Flat Price All Doses) |
| Effective $/mg (2.4 mg/wk Semaglutide) | $41.35/mg | $5.10 / mg |
| Minimum Contract Commitment | 1 Month | 1 Month (Cancel Anytime) |
| 52-Week Cumulative Semaglutide Spend | $4,761 | $637 (13 Four-Week Cycles @ $49) |
Key Consumer Finding: Henry Meds
Adds $100/month extra once patients titrate past 1.0 mg/wk semaglutide or 10 mg/wk tirzepatide.
Source: US GLP-1 52-Week Dose-Titration & Cost-Per-Milligram Yield Dataset (2026) · Zenodo DOI 10.5281/zenodo.24139315.